Here at KMK we understand that in order to play optimally in a new disease space you must first understand its market structure, dynamics, and competition. We believe tailored up-to-date data is the best starting point for strategic decision making. To ensure all projects optimally achieve their objectives, research, analysis and insight identification are all performed by senior team members.

To help brands find their place in the market:

  • We provide a ‘storylined integration of insights’ vs. a ‘menu dump’ while still delivering a  rigorous break down of the market including competitive landscape, saturation points and unmet needs
  • We help teams define data-based strategies for their new indication, product or acquisition

KMK's cross-business unit expertise incorporates a variety of research types, and the robustness of research is tailored to your needs.

Primary Market Research

Opportunity Assessment

  • Perception of product & potential use cases
  • Identification of unmet needs met by product

Unmet Needs Evaluation

  • Identify white space within the market
  • Understand who is underserved within market population

Payer Attitudinal Assessment

  • Gain understanding of payer perspectives
  • Get guidance on potential access and coverage needs

Baseline ATU

  • Evaluate current stakeholder awareness and usage

Secondary Data Evaluation

Target Market Potential

  • Define the market (key drug classes/products)

  • Market sizing

  • Historical events impacts

Analogue Identification & Evaluation

  • Approximate environmental factors and potential reception including challenges and access

Preliminary Customer Identification & Profiling

  • Potential by HCP specialty; top specialties/HCPs, early adopters

  • Potential by account types; top accounts

  • Patient profile (demographic and clinical)

  • Referral network analytics

  • Behavioral segmentation (HCP)

Desk Research

Product Overview

  • Review and analysis of previously completed research

  • Asset and pipeline understanding


  • KOL identification

  • Foundation/3rd Party

  • Investment and research

  • Advocacy support group analysis

Disease Landscape

  • Epidemiology

  • Treatment approaches and clinical guidelines

  • Treatment algorithm changes over time due to new drug additions or new information

Competitive Landscape

  • Pipeline assessment

  • Market events

Get ahead with enhanced market understanding

Our expert market research team is here to guide you, every step of the way. Get in touch today.

Related insights: